These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 32205565)

  • 21. Idiosyncratic Drug-Induced Liver Injury Associated With and Without Drug Reaction With Eosinophilia and Systemic Symptoms.
    Devarbhavi H; Kurien SS; Raj S; Patil M; Gowda V; Kothari K; Singh R
    Am J Gastroenterol; 2022 Oct; 117(10):1709-1713. PubMed ID: 35862835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-Induced Liver Injury in Children: Clinical Observations, Animal Models, and Regulatory Status.
    Shi Q; Yang X; Greenhaw JJ; Salminen AT; Russotti GM; Salminen WF
    Int J Toxicol; 2017; 36(5):365-379. PubMed ID: 28820004
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Recurrent drug-induced liver injury (DILI) with ciprofloxacin and amoxicillin/clavulanic.
    Moreno L; Sánchez-Delgado J; Vergara M; Casas M; Miquel M; Dalmau B
    Rev Esp Enferm Dig; 2015 Dec; 107(12):767-8. PubMed ID: 26671593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Case Characterization, Clinical Features and Risk Factors in Drug-Induced Liver Injury.
    Ortega-Alonso A; Stephens C; Lucena MI; Andrade RJ
    Int J Mol Sci; 2016 May; 17(5):. PubMed ID: 27187363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Genetics of drug-induced liver injury: Current knowledge and future prospects.
    Daly AK
    Clin Transl Sci; 2023 Jan; 16(1):37-42. PubMed ID: 36194091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Investigation of Oxidative Stress-Related Candidate Genes as Risk Factors for Drug-Induced Liver Injury due to Co-Amoxiclav.
    Alshabeeb MA; Aithal GP; Daly AK
    DNA Cell Biol; 2020 Mar; 39(3):349-354. PubMed ID: 31905014
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Idiosyncratic drug-induced liver injury: a clinical update.
    Maddur H; Chalasani N
    Curr Gastroenterol Rep; 2011 Feb; 13(1):65-71. PubMed ID: 21049293
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Drug-induced liver injury: recent advances in diagnosis and risk assessment.
    Kullak-Ublick GA; Andrade RJ; Merz M; End P; Benesic A; Gerbes AL; Aithal GP
    Gut; 2017 Jun; 66(6):1154-1164. PubMed ID: 28341748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Liver Injury in COVID-19 Patients with Drugs as Causatives: A Systematic Review of 996 DILI Cases Published 2020/2021 Based on RUCAM as Causality Assessment Method.
    Teschke R; Méndez-Sánchez N; Eickhoff A
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for severe or fatal drug-induced liver injury from amoxicillin-clavulanic acid.
    Yazici C; Mutlu E; Bonkovsky HL; Russo MW
    Hepatol Res; 2015 Jun; 45(6):676-82. PubMed ID: 25163514
    [TBL] [Abstract][Full Text] [Related]  

  • 31. NAT2 slow acetylator associated with anti-tuberculosis drug-induced liver injury in Thai patients.
    Wattanapokayakit S; Mushiroda T; Yanai H; Wichukchinda N; Chuchottawon C; Nedsuwan S; Rojanawiwat A; Denjanta S; Kantima T; Wongyai J; Suwankesawong W; Rungapiromnan W; Kidkeukarun R; Bamrungram W; Chaiwong A; Suvichapanich S; Mahasirimongkol S; Tokunaga K
    Int J Tuberc Lung Dis; 2016 Oct; 20(10):1364-1369. PubMed ID: 27725049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Drug-induced liver injury in hospitalized patients with notably elevated alanine aminotransferase.
    Xu HM; Chen Y; Xu J; Zhou Q
    World J Gastroenterol; 2012 Nov; 18(41):5972-8. PubMed ID: 23139615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predicting and preventing acute drug-induced liver injury: what's new in 2010?
    Liss G; Rattan S; Lewis JH
    Expert Opin Drug Metab Toxicol; 2010 Sep; 6(9):1047-61. PubMed ID: 20615079
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of Prior Drug Allergies on the Risk, Clinical Features, and Outcomes of Idiosyncratic Drug-Induced Liver Injury in Adults.
    Yeboah-Korang A; Memon A; Patel N; Portocarrero-Castillo A; Osman A; Kleesattel D; Lopez C; Louissaint J; Sherman K; Fontana R
    Dig Dis Sci; 2022 Nov; 67(11):5262-5271. PubMed ID: 35122190
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Approach to Drug-Induced Liver Injury from the Geriatric Perspective.
    Lee BT; Odin JA; Grewal P
    Curr Gastroenterol Rep; 2021 Apr; 23(4):6. PubMed ID: 33846832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and Liver Biochemistry Phenotypes, and Outcome in 133 Patients with Anti-seizure Drug-Induced Liver Injury.
    Devarbhavi H; Sridhar A; Kurien SS; Gowda V; Kothari K; Patil M; Singh R
    Dig Dis Sci; 2023 May; 68(5):2099-2106. PubMed ID: 36484972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Herbal and Dietary Supplement-Induced Liver Injuries in the Spanish DILI Registry.
    Medina-Caliz I; Garcia-Cortes M; Gonzalez-Jimenez A; Cabello MR; Robles-Diaz M; Sanabria-Cabrera J; Sanjuan-Jimenez R; Ortega-Alonso A; García-Muñoz B; Moreno I; Jimenez-Perez M; Fernandez MC; Ginés P; Prieto M; Conde I; Hallal H; Soriano G; Roman E; Castiella A; Blanco-Reina E; Montes MR; Quiros-Cano M; Martin-Reyes F; Lucena MI; Andrade RJ;
    Clin Gastroenterol Hepatol; 2018 Sep; 16(9):1495-1502. PubMed ID: 29307848
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Current and future directions in the treatment and prevention of drug-induced liver injury: a systematic review.
    Stine JG; Lewis JH
    Expert Rev Gastroenterol Hepatol; 2016; 10(4):517-36. PubMed ID: 26633044
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Highlights of drug - and herb- induced liver injury in the literature from 2016: how best to translate new information into clinical practice?
    Shahbaz O; Mahajan S; Lewis JH
    Expert Opin Drug Metab Toxicol; 2017 Sep; 13(9):935-951. PubMed ID: 28772086
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of drug-induced liver injury associated with drug reaction with eosinophilia and systemic symptoms in two prospective DILI registries.
    Medina-Cáliz I; Sanabria-Cabrera J; Villanueva-Paz M; Aukštikalnė L; Stephens C; Robles-Díaz M; Pinazo-Bandera JM; García-Cortes M; Conde I; Soriano G; Bessone F; Hernandez N; Nunes V; Paraná R; Lucena MI; Andrade RJ; Niu H; Alvarez-Alvarez I
    Arch Toxicol; 2024 Jan; 98(1):303-325. PubMed ID: 38051367
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.